Fig. 7From: Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant MontanideLevel of INFγ-producing CD8+ T cells. The proportions of INFγ − producing CD8+ T cells in mice immunized with 25 μg of P467-CRM conjugate administered with Alum or Montanide, are shown. The statistical analysis was performed using t test. Significant difference is denoted by asterisks Back to article page